|
T6587 |
Mitiglinide Calcium
|
KAD-1229,S21403 |
ATPase
,
Potassium Channel
|
|
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. |
|
T1530 |
Mitiglinide calcium hydrate
|
KAD-1229 calcium hydrate,Mitiglinide calcium,S-21403 calcium hydrate |
Potassium Channel
|
|
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic ... |
|
T16009L |
Managlinat dialanetil
|
MB06322,MB 6322,CS-917 |
Phosphatase
|
|
Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes. |
|
T19710 |
Ciglitazone
|
Ciglitazona,U 63287,ADD3878,ADD-3878,U-63287,ADD 3878 |
Apoptosis
,
p38 MAPK
,
PPAR
|
|
Ciglitazone (ADD 3878) is a potent and selective PPARγ agonist (EC50: 3 μM) and oral hypoglycemic agent. Ciglitazone inhibits proliferation and differentiation of th17 cells, decreases insulin levels, vascular endothelia... |
|
T15013 |
CS476
|
NSC302998 |
Others
|
|
CS476 is a potent drug of hypoglycaemic. |
|
T68602 |
AZ-DF 265
|
|
|
|
AZ-DF 265 is a hypoglycaemic drug which stimulates insulin release. AZ-DF-265 inhibits ATP-sensitive potassium channels and displaces [3H]-glibenclamide from the sulphonylurea receptor. |
|
T62821 |
Cadisegliatin
|
|
|
|
Cadisegliatin (TTP-399) is a potential activator of liver-selective glucose kinase (GK) with hypoglycaemic effects and can be used in the study of type 2 diabetes. |
|
T62985 |
Cofrogliptin
|
|
|
|
Cofrogliptin (HSK7653) (compound 2) is a tetrahydropyran derivative that is an orally active DPP-4 inhibitor with long-lasting hypoglycaemic effects.Cofrogliptin (compound 2) has potential for studies in type 2 diabetes ... |
